Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1442.195
  • -8.013-0.55%
Trading Dec 12 13:32 ET
1450.437High1429.426Low
Constituent Stocks: 10Top Rising: A+0.18%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
AAgilent Technologies
141.4400.250+0.18%332.93K46.95M140.410141.190141.715139.88040.34B40.19B285.19M284.11M+2.59%+2.39%+5.33%+1.91%+5.07%+3.22%+2.25%0.67%0.12%31.9331.931.30%Diagnostics & Research
VRTXVertex Pharmaceuticals
466.097-2.193-0.47%354.77K164.26M466.520468.290469.758460.050120.03B119.69B257.53M256.79M+1.34%+0.33%-5.76%-1.70%-1.86%+14.63%+14.55%--0.14%Loss33.562.07%Biotechnology
BLUEbluebird bio
0.383-0.009-2.20%3.12M1.22M0.3900.3920.4100.37274.47M74.13M194.44M193.54M-13.70%+1.38%+1.78%-22.63%-62.45%-88.39%-72.25%--1.61%LossLoss9.73%Biotechnology
CRSPCRISPR Therapeutics
46.570-1.210-2.53%858.22K40.22M47.46047.78047.68046.2803.97B3.91B85.35M83.95M-5.94%-8.40%-6.47%-6.09%-19.62%-26.01%-25.61%--1.02%LossLoss2.93%Biotechnology
CRBUCaribou Biosciences
1.955-0.065-3.22%650.27K1.28M2.0302.0202.0301.930177.03M159.49M90.55M81.58M-0.76%-11.14%-11.14%-6.01%+4.55%-68.31%-65.88%--0.80%LossLoss4.95%Biotechnology
BEAMBeam Therapeutics
27.875-1.025-3.55%482.50K13.49M28.68028.90028.89027.4502.31B1.91B82.81M68.63M+10.09%+2.48%+1.36%+9.27%+12.26%-6.43%+2.41%--0.70%LossLoss4.98%Biotechnology
NTLAIntellia Therapeutics
13.585-0.515-3.65%797.74K10.94M14.05014.10014.05013.4601.38B1.37B101.85M100.57M-0.48%-10.68%-15.67%-39.68%-45.66%-57.36%-55.44%--0.79%LossLoss4.18%Biotechnology
APLSApellis Pharmaceuticals
32.485-1.515-4.46%700.75K23.23M33.53034.00034.09532.4204.04B2.74B124.39M84.36M-2.88%-4.85%+14.99%-8.83%-15.45%-37.74%-45.73%--0.83%LossLoss4.93%Biotechnology
SGMOSangamo Therapeutics
1.838-0.102-5.28%1.96M3.66M1.9001.9401.9301.820383.41M374.94M208.65M204.04M-6.72%-20.10%-24.69%+119.52%+291.15%+327.35%+238.23%--0.96%LossLoss5.67%Biotechnology
EDITEditas Medicine
1.881-0.109-5.47%1.64M3.12M1.9901.9902.0001.860155.28M145.45M82.55M77.32M-1.51%-14.50%-36.45%-51.52%-62.97%-82.65%-81.43%--2.12%LossLoss7.04%Biotechnology

Comments

Read more